back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2020-01-08 11:36 Tx date 2020-01-07 |
$RVV
Revive Therapeutics Ltd. |
Leon, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-600,000 vol |
0 | |
| Filed 2019-06-19 14:50 Tx date 2019-06-19 |
$RVV
Revive Therapeutics Ltd. |
Leon, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
99 - Correction of information
|
+24,000 vol |
1,154,000 | |
| Filed 2019-06-19 14:40 Tx date 2013-12-30 |
$RVV
Revive Therapeutics Ltd. (formerly, Mercury Capital II Limited) |
Leon, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Rangercap Inc. (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$67,500
+225,000 vol $0.30 each |
225,000 | |
| Filed 2014-01-09 21:28 Tx date 2013-12-30 |
$RVV
Revive Therapeutics Ltd. (formerly, Mercury Capital II Limited) |
Leon, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Rangercap Inc. (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$75,000
+250,000 vol $0.30 each |
||
| Filed 2017-12-22 Tx date 2017-12-18 |
$RVV
Revive Therapeutics Ltd. |
Leon, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-125,000 vol |
0 | |
| Filed 2017-12-22 Tx date 2017-12-18 |
$RVV
Revive Therapeutics Ltd. |
Leon, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$22,500
+125,000 vol $0.18 each |
1,255,000 | |
| Filed 2017-12-22 Tx date 2017-12-18 |
$RVV
Revive Therapeutics Ltd. |
Leon, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-38,750
-125,000 vol $0.31 each |
1,130,000 | |
| Filed 2017-06-30 Tx date 2017-06-28 |
$RVV
Revive Therapeutics Ltd. |
Leon, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-206,800
-940,000 vol $0.22 each |
1,130,000 | |
| Filed 2017-04-12 Tx date 2017-04-10 |
$RVV
Revive Therapeutics Ltd. |
Leon, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
600,000 | |
| Filed 2016-06-20 Tx date 2016-06-17 |
$RVV
Revive Therapeutics Ltd. |
Leon, Craig
4 - Director of Issuer
Holder: Rangercap Inc. (Control or Direction)
|
Rights
58 - Expiration of rights
|
-250,000 vol |
0 | |
| Filed 2016-06-20 Tx date 2016-06-17 |
$RVV
Revive Therapeutics Ltd. |
Leon, Craig
4 - Director of Issuer
Direct Ownership
|
Rights
58 - Expiration of rights
|
-1,570,000 vol |
0 | |
| Filed 2016-06-20 Tx date 2013-12-30 |
$RVV
Revive Therapeutics Ltd. |
Leon, Craig
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-06-20 Tx date 2016-06-17 |
$RVV
Revive Therapeutics Ltd. |
Leon, Craig
4 - Director of Issuer
Direct Ownership
|
Warrants
57 - Exercise of rights
|
+125,000 vol |
125,000 | |
| Filed 2016-06-20 Tx date 2016-06-17 |
$RVV
Revive Therapeutics Ltd. |
Leon, Craig
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+250,000 vol |
2,070,000 | |
| Filed 2016-06-20 Tx date 2016-06-17 |
$RVV
Revive Therapeutics Ltd. |
Leon, Craig
4 - Director of Issuer
Direct Ownership
|
Rights
57 - Exercise of rights
|
-250,000 vol |
1,570,000 | |
| Filed 2016-05-24 Tx date 2016-05-20 |
$RVV
Revive Therapeutics Ltd. |
Leon, Craig
4 - Director of Issuer
Holder: Rangercap Inc. (Control or Direction)
|
Rights
56 - Grant of rights
|
+250,000 vol |
250,000 | |
| Filed 2016-05-24 Tx date 2013-12-30 |
$RVV
Revive Therapeutics Ltd. |
Leon, Craig
4 - Director of Issuer
Direct Ownership
|
Rights
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-05-24 Tx date 2016-05-20 |
$RVV
Revive Therapeutics Ltd. |
Leon, Craig
4 - Director of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+1,820,000 vol |
1,820,000 | |
| Filed 2016-05-24 Tx date 2013-12-30 |
$RVV
Revive Therapeutics Ltd. |
Leon, Craig
4 - Director of Issuer
Holder: Rangercap Inc. (Control or Direction)
|
Rights
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-08-18 Tx date 2015-06-10 |
$
Revelstoke Equity Inc. |
Leon, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-08-18 Tx date 2015-08-12 |
$
Revelstoke Equity Inc. |
Leon, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$42,893
+214,465 vol $0.20 each |
214,465 | |
| Filed 2015-06-18 Tx date 2015-06-10 |
$
Revelstoke Equity Inc. |
Leon, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
750,000 | ||
| Filed 2015-06-15 Tx date 2015-06-12 |
$RVV
Revive Therapeutics Ltd. |
Leon, Craig
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-140,000
-200,000 vol $0.70 each |
1,820,000 | |
| Filed 2015-04-30 Tx date 2015-04-22 |
$RVV
Revive Therapeutics Ltd. |
Leon, Craig
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+1,500,000 vol |
2,020,000 |